T1	Participants 57 134	patients with left-ventricular dysfunction after recent myocardial infarction
T2	Participants 309 353	patients with poor left-ventricular function
T3	Participants 692 850	patients at high risk of death after myocardial infarction because of impaired ventricular function, irrespective of whether they had ventricular arrhythmias.
T4	Participants 1295 1364	1486 patients (743 in the amiodarone group, 743 in the placebo group)
